AGAP2 and non-small cell lung carcinoma: Our previous study showed that the combination of two exosomal lncRNAs (TBILA and AGAP2-AS1) failed to provide better results than individual exosomal lncRNAs in the detection of non-small-cell lung cancer (NSCLC) with pathologic subtypes and early-stage (29).